Merck & Co. Inc. | 2013 | FY | 3


Presented in the table below is the fair value of derivatives on a gross basis segregated between those derivatives that are designated as hedging instruments and those that are not designated as hedging instruments as of December 31:
 
 
 
2013
 
2012
 
 
 
Fair Value of
Derivative
 
U.S. Dollar
Notional
 
Fair Value of
Derivative
 
U.S. Dollar
Notional
 
Balance Sheet Caption
 
Asset
 
Liability
 
Asset
 
Liability
 
Derivatives Designated as Hedging Instruments
 
 
 
 
 
 
 
 
 
 
 
 
 
Interest rate swap contracts (non-current)
Other assets
 
$
13

 
$

 
$
1,550

 
$

 
$

 
$

Interest rate swap contracts (non-current)
Other noncurrent liabilities
 

 
25

 
2,000

 

 

 

Foreign exchange contracts (current)
Deferred income taxes and other current assets
 
493

 

 
4,427

 
281

 

 
6,646

Foreign exchange contracts (non-current)
Other assets
 
515

 

 
6,676

 
387

 

 
5,989

Foreign exchange contracts (current)
Accrued and other current liabilities
 

 
19

 
1,659

 

 
13

 
938

 
 
 
$
1,021

 
$
44

 
$
16,312

 
$
668

 
$
13

 
$
13,573

Derivatives Not Designated as Hedging Instruments
 
 
 
 
 
 
 
 
 
 
 
 
 
Foreign exchange contracts (current)
Deferred income taxes and other current assets
 
$
69

 
$

 
$
5,705

 
$
55

 
$

 
$
4,548

Foreign exchange contracts (non-current)
Other assets
 

 

 

 
8

 

 
232

Foreign exchange contracts (current)
Accrued and other current liabilities
 

 
140

 
7,892

 

 
216

 
8,203

 
 
 
$
69

 
$
140

 
$
13,597

 
$
63

 
$
216

 
$
12,983

 
 
 
$
1,090

 
$
184

 
$
29,909

 
$
731

 
$
229

 
$
26,556


us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock